Caliper Life Sciences, Inc. (CALP) Tops Q2 EPS by 4c, Posts Q3 and FY11 Revenue Guidance
Get Alerts CALP Hot Sheet
Price: $10.49 --0%
Financial Fact:
Net income (loss) per share, diluted (in dollars per share): -0.01
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Net income (loss) per share, diluted (in dollars per share): -0.01
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Caliper Life Sciences, Inc. (NASDAQ: CALP) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $38.3 million versus the consensus estimate of $34.39 million.
Caliper Life Sciences, Inc. sees Q3 2011 revenue of $33-$36 million, versus the consensus of $34.72 million.
Caliper Life Sciences, Inc. sees FY2011 revenue of $146-$152 million, versus the consensus of $144.01 million.
Caliper Life Sciences, Inc. sees Q3 2011 revenue of $33-$36 million, versus the consensus of $34.72 million.
Caliper Life Sciences, Inc. sees FY2011 revenue of $146-$152 million, versus the consensus of $144.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share